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Maternal Smoking During Pregnancy and 
Offspring Health Outcomes: The Role of 
Epigenetic Research in Informing Legal Policy 
and Practice 
Taylor F. Smith,* Matthew A. Maccani,** and Valerie S. Knopik*** 
Scientific advances in epidemiology and epigenetics emphasize the importance of 
prenatal and intergenerational environmental influences and epigenetic regulation in 
altering vulnerability for later health outcomes. These findings may have wide-ranging 
legal implications; however, to avoid misapplication, a thorough understanding of the 
scientific literature and legal precedent is warranted. A growing body of literature 
suggests that negative health outcomes associated with prenatal smoke exposure may 
result, in part, from aberrant epigenetic regulation of gene expression. Such findings 
emphasize the need to reduce rates of prenatal cigarette smoke exposure in order to 
promote health for both current and future generations. This Article provides a focused 
overview of research examining the interrelationships between maternal smoking 
during pregnancy, epigenetic regulation, and vulnerability for later health outcomes. 
Additionally, this Article discusses legal, ethical, and policy challenges related to 
reducing smoke exposure during pregnancy. 
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Introduction 
One’s prenatal environment, and in some cases the prenatal 
environment of one’s ancestors, may contribute to the development of 
cardiovascular disease, type 2 diabetes, obesity, cancer, and 
neurodevelopmental disorders.1 Recent advances in epidemiological 
theory2 and epigenetics3 have led to a major paradigm shift in research 
investigating the causes of later health and behavior. These advances 
provide a useful framework and novel tools to help examine how early 
environmental influences impact vulnerability for later health outcomes. 
Many of society’s most costly,4 impairing, and deadly diseases5 have 
early developmental origins.6 From a public health perspective, these 
findings hold great promise as preventative interventions may aim to 
reduce exposure to adverse environmental influences. Furthermore, there 
has been increased interest in understanding the processes linking early 
environments—even those from previous generations—to later health 
outcomes. Epigenetic mechanisms may provide a bridge for how the 
environment gets “under the skin” and impacts biological vulnerability to 
future diseases and complications. Future health interventions may also 
target modifiable epigenetic mechanisms.7 
In addition to public health implications, the role of early 
environmental influences and related epigenetic mechanisms on later 
health challenges may have wide-ranging implications for legal policy 
and practice. A growing body of literature suggests that negative health 
outcomes associated with prenatal smoke exposure may result partially 
from aberrant epigenetic regulation of gene expression. Furthermore, 
intergenerational epigenetic effects may transmit the adverse effects of 
 
 1. See Tessa Roseboom et al., The Dutch Famine and its Long-Term Consequences for Adult 
Health, 82 Early Hum. Dev. 485, 486 (2006). 
 2. Epidemiological theory, such as the “developmental origins of health and disease” hypothesis, 
provides a framework for understanding the causes and patterns of disease. See generally Peter D. 
Gluckman & Mark A. Hanson, Living with the Past: Evolution, Development, and Patterns of Disease, 
305 Science 1733 (2004). 
 3. Epigenetics researches changes in gene expression that are not caused by changes in the 
sequence of DNA. See generally Adrian Bird, Perceptions of Epigenetics, 447 Nature 396 (2007). 
 4. See generally Benjamin G. Druss et al., The Most Expensive Medical Conditions In America, 
21 Health Aff., no. 4, 2002, at 105. 
 5. See Arialdi M. Minino & Betty L. Smith, Ctrs. for Disease Control & Prevention, 49 
National Vital Statistics Reports 12, at 2–4 (Oct. 2001) (discussing the leading causes of death from 
1999–2000, including diseases). 
 6. See generally Robert Barouki et al., Developmental Origins of Non-Communicable Disease: 
Implications for Research and Public Health, Environmental Health (Jun. 27, 2012, 11:42 AM), 
http://www.ehjournal.net/content/11/1/42. 
 7. See infra Part I.B.3. 
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cigarette smoke exposure from one generation to the next.8 If aberrant 
epigenetic effects are found to link environmental exposure with negative 
health outcomes, then epigenetic evidence may be considered when 
determining criminal culpability or negligence of the “bad actor” who has 
exposed others to cigarette smoke. In addition, given that smoking-
associated negative health outcomes may be realized in subsequent 
generations through epigenetic transmission, problems may also arise in 
applying statutes of limitation to such cases. Consider these examples of 
potential cases: 
If a grandmother smoked during her pregnancy with a daughter, 
should that grandmother be held responsible for smoking-associated 
diseases and symptoms present in her grandchild—even if that 
grandchild’s only exposure to cigarette smoke resulted from her mother’s 
prenatal exposure to smoke? 
The literature on the potential hazards of passive (or “secondhand”) 
smoke has grown substantially. Due to this growing awareness, might a 
father who smoked near a pregnant woman be held liable for negative 
smoking-related health consequences that result from the many chemicals 
now known to be present in secondhand smoke? Given that even small 
doses of harmful exposures can lead to deleterious effects, what level of 
cigarette smoke exposure would be considered prosecutable? 
This Article highlights the potential ethical, legal, and policy issues 
stemming from research on the developmental origins of later health 
outcomes. Part I provides background and an overview of the 
Developmental Origins of Health and Disease model, with an emphasis on 
fetal programming. Part II discusses epigenetic concepts within the context 
of environmental epigenetics and reviews the impact of smoke exposure in 
utero on epigenetic processes and health outcomes. The Article concludes, 
in Part III, with a discussion of ethical, legal, and policy implications of the 
interpretation and application of epigenetic findings. 
I.  Fetal Origins of Later Health Outcomes 
A. Barker’s Hypothesis and the Dutch Famine of 1944–1945 
Multiple epidemiological studies have observed that populations 
exposed to a limited nutrient supply in utero and who experienced 
restricted fetal growth are at greater risk for diseases later in life.9 Barker’s 
Hypothesis, which stems from these observations, states that fetal 
 
 8. See generally Dawn P. Misra et al., Maternal Smoking and Birth Weight: Interaction with 
Parity and Mother’s Own In Utero Exposure to Smoking, 16 Epidemiology 288 (2005). 
 9. See, e.g., D.J.P. Barker, The Origins of the Developmental Origins Theory, 261 J. Internal 
Med. 412 (2007); Pathik D. Wadhwa et al., Developmental Origins of Health and Disease: Brief History of 
the Approach and Current Focus on Epigenetic Mechanisms, 27 Seminars Reprod. Med. 358 (2009). 
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undernourishment leads to lasting alterations in the structure and function 
of organs and subsequent increased vulnerability for adult disease.10 In 
particular, the Dutch Famine Birth Cohort study11 has offered key, but 
tragic, insights into the association of fetal malnutrition with later health. 
In support of the Allied Forces’ momentum during World War II, 
the exiled Dutch government called for a strike of the national 
railroads.12 In response, the German administration placed a food 
transport embargo on the western Netherlands, which was still under 
German control.13 The embargo was altered in November 1944 to allow 
food transport by water, but due to an early and harsh winter, this form of 
transport was not feasible.14 The embargo and harsh winter led to famine 
in the western Netherlands, and as a result, adult daily rations dropped to 
between 400–800 calories from December 1944 to April 1945, and 
supplementary calories for women who were pregnant or nursing were 
no longer available.15 
The Dutch Famine (or Hunger Winter) was associated with 
significant morbidity and mortality. The link between in utero 
environment and later health outcomes was illuminated by historical 
circumstances such as the circumscribed period of the famine, detailed 
records of daily rations and health outcomes and limited supply of 
supplemental food. The Dutch Famine Birth Cohort Study followed 
individuals who were exposed to the famine prenatally and assessed 
associations of prenatal malnutrition with later health outcomes. Results 
from this study demonstrated that fetal malnutrition was associated with 
increased risk for various non-communicable health and 
neurodevelopmental problems including cardiovascular disease,16 type 2 
diabetes,17 cancer,18 obesity,19 and schizophrenia.20 The relationship 
between fetal malnutrition and later health outcomes also depended on 
the gestational timing of famine.21 These findings emphasize the critical 
importance of environmental influences during prenatal development and 
 
 10. Barker, supra note 9, at 412. 
 11. Roseboom et al., Effects of Prenatal Exposure to the Dutch Famine on Adult Disease in Later 
Life: An Overview, 185 Molecular & Cellular Endocrinology 93 (2001). 
 12. Id. at 94. 
 13. Id. 
 14. Id. 
 15. Id. 
 16. Rosenbloom et al., supra note 1, at 489. 
 17. Id. at 487–88. 
 18. Id. at 489. 
 19. See generally Gian-Paolo Ravelli et al., Obesity in Young Men After Famine Exposure In 
Utero and Early Infancy, 295 New Eng. J. Med. 349 (1976). 
 20. See generally E.S. Susser & S.P. Lin, Schizophrenia After Prenatal Exposure to the Dutch 
Hunger Winter of 1944–1945, 49 Archives Gen. Psychiatry 983 (1992). 
 21. Rosenbloom et al., supra note 1, at 488.  
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that vulnerability for a specified health outcome may relate to both the 
timing and nature of prenatal environmental exposures. 
B. The Developmental Origins of Health and Disease Hypothesis 
Findings from the Dutch Famine Birth Cohort study emphasize the 
critical importance of the prenatal period in the programming of multiple 
developmental systems. Other studies of humans and animals have 
broadened our understanding of adverse prenatal environmental 
influences and their relationship to later health outcomes. Such studies 
have shown, for example, that exposure to toxicants (such as cigarette 
smoke), maternal illnesses (such as influenza or depression), medications 
(such as antidepressants), fetal hypoxia, and other pregnancy 
complications have an adverse impact on later health.22 To account for 
these findings, Barker’s hypothesis was expanded to the Developmental 
Origins of Health and Disease hypothesis (“DOHaD”).23 
DOHaD provides a comprehensive framework to conceptualize 
how the interplay of genetic and early environmental factors can cause 
vulnerability for later health, behavior, and disease. DOHaD 
hypothesizes that prenatal environmental influences contribute to the 
programming of the fetus and, in a way, attempt to impart a maternal 
forecast on the developing fetus. The theory of “fetal programming”24 
postulates that a large milieu of exposures comprise the prenatal 
environment, including nutrients, drugs, trauma, and stress. A prenatal 
environment comprised mostly of healthy exposures and proper nutrition 
and devoid of negative exposures is theorized to result in the mother 
imparting a rich maternal forecast on her fetus—a prediction that the 
postnatal environment will be one in which resources are plentiful and 
harmful negative exposures are minimal.25 On the contrary, a largely 
adverse prenatal environment (one comprised of a number of negative 
exposures and mostly devoid of positive environmental influences) is 
theorized to result in a mother imparting a poor maternal forecast on her 
fetus, which is often characterized by restricted fetal growth.26 This 
negative maternal forecast predicts that the postnatal environment will 
be one in which positive resources and exposures are scarce while 
 
 22. See, e.g., K. Latimer et al., Disruptive Behaviour Disorders: A Systematic Review of Environmental 
Antenatal and Early Years Risk Factors, 38 Child: Care, Health & Dev. 609, 611–28 (2012). 
 23. See generally Gluckman & Hanson, supra note 2. 
 24. Valerie S. Knopik et al., The Epigenetics of Maternal Cigarette Smoking During Pregnancy 
and Effects on Child Development, 24 Dev. & Psychopathology 1377, 1379 (2012). 
 25. Id. 
 26. See generally C.N. Hales & D.J.P. Barker, Type 2 (Non-Insulin-Dependent) Diabetes Mellitus: the 
Thrifty Phenotype Hypothesis, 35 Diabetologia 595 (1992). According to Hales and Barker the “thrifty 
phenotype” describes the notion that fetal malnutrition is associated with restricted fetal growth and 
lasting changes in glucose-insulin metabolism which increases vulnerability for metabolic problems, 
including type 2 diabetes, when exposed to a nutrient rich postnatal environment. See generally id. 
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negative exposures are abundant. Moreover, maternal forecasts that are 
discordant with the post-birth environment—that incorrectly predict the 
post-birth environment—have been hypothesized to be associated with a 
number of negative consequences for the child later in life, such as an 
increased risk for cardiovascular and metabolic diseases. This outcome 
was observed in many of the children exposed to in utero famine during 
the Dutch Hunger Winter, who were imparted with negative maternal 
forecasts and were born growth-restricted but who experienced a post-
birth environment that was abundant with resources.27 
Increased vulnerability for poor health outcomes may result from 
multiple developmental processes including, but not limited to, predictive 
adaptive responses, developmental delays, or developmental disruptions. 
Predictive adaptive responses describe an organism’s prenatal structural 
and functional adaptations to promote survival in a similar postnatal 
environment.28 Vulnerability for poor health outcomes may then arise 
from a mismatch between the prenatal and postnatal environment. This 
mismatch confers vulnerability for disease as the organism is functioning in 
an environment for which it did not prepare. As a result, the fetus may be 
ill-equipped to function adaptively in the postnatal environment. For 
example, in response to a decreased placental-fetal blood flow, a fetus may 
preferentially direct blood flow and nutrients to the brain, known as the 
“brain-sparing effect.”29 Although this may promote neurovascular 
functioning in a nutrient poor environment, it may also constrain cerebral 
vascular plasticity later in life.30  
In addition, brain-sparing blood flow does not completely protect 
against later behavioral problems31 as the nutrient and oxygen availability 
is more abundant in the postnatal environment. Prenatal environmental 
influences may also cause vulnerability for later health problems by 
disrupting developmental processes. For example, exposure to teratogens, 
including several compounds in cigarette smoke,32 may disrupt 
developmental processes without any forecasted or actual adaptive 
advantage. Although prenatal environmental influences may directly 
 
 27. See Knopik, supra note 24, at 1379; see also David J.P. Barker & Phillipa M. Clark, Fetal 
Undernutrition and Disease in Later Life, 2 Revs. Reprod. 105, 109 (1997); Susanne R. de Rooij et al., 
Prenatal Undernutrition and Cognitive Function in Late Adulthood, 107 Proceedings Nat’l Acad. Sci. 
U.S. 16881, 16883 (2010). 
 28. See generally Gluckman & Hanson, supra note 2. Predictive adapted responses describe the 
process of fetal programming in response to the prenatal milieu. Id. 
 29. Ahmet A. Baschat, Fetal Responses to Placental Insufficiency: An Update, 111 BJOG: Int’l J. 
Obstetrics & Gynaecology 1031, 1035 (2004). 
 30. Jing Fu & Per Olofsson, Restrained Cerebral Hyperperfusion in Response to Superimposed 
Acute Hypoxemia in Growth-Restricted Human Fetuses with Established Brain-Sparing Blood Flow, 
82 Early Hum. Dev. 211, 215 (2006). 
 31. Sabine J. Roza et al., What Is Spared by Fetal Brain-Sparing? Fetal Circulatory Redistribution 
and Behavioral Problems in the General Population, 168 Am. J. Epidemiology 1145, 1145 (2008). 
 32. See generally Knopik, supra note 24. 
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impact vulnerability for later health outcomes, it is important to consider 
indirect effects and the role of other factors. Among individuals exposed to 
adverse prenatal environmental influences, vulnerability for later health 
outcomes may then be moderated by the postnatal environment and 
genetic effects. 
1. Postnatal Environmental Influences 
The postnatal environment continues to impact vulnerability for 
health outcomes throughout life. For example, rat pups that are exposed 
to low levels of maternal nurturing behavior (such as licking, grooming, 
and arched back nursing) exhibit increased fearful behavior and 
hypothalamic-pituitary-adrenal axis response to stress compared to pups 
exposed to high levels of maternal nurturing behavior.33 This postnatal 
environmental effect is believed to be mediated, in part, by differences in 
DNA methylation of the glucocorticoid receptor gene in the 
hippocampus—an epigenetic mechanism described in detail in 
Part I.B.3.34 Although preliminary, findings in studies of humans suggest 
that maternal nurturing behavior like infant stroking may produce 
similar behavioral outcomes.35 The mechanism underlying this 
relationship in humans has not yet been fully examined but these 
findings demonstrate that postnatal environmental experiences may also 
impact vulnerability for later health outcomes. 
2. Intergenerational Transmission of Environmental Effects 
Environmental influences may also impact health outcomes in 
subsequent generations. For example, prenatal cigarette smoke exposure 
may put offspring at risk for poor health outcomes (such as low birth 
weight) and this relationship has been shown to be exacerbated in 
mothers who themselves were exposed to maternal smoking during their 
own fetal development.36 These findings suggest that environmental 
exposures may have a multi-generational impact on health outcomes, 
which emphasizes the public health significance of limiting exposure to 
adverse environmental factors.37 
 
 33. Ian C.G. Weaver et al., Epigenetic Programming by Maternal Behavior, 7 Nature 
Neuroscience 847, 847 (2004). 
 34. Id. 
 35. Helen Sharp et al., Frequency of Infant Stroking Reported by Mothers Moderates the Effect of 
Prenatal Depression on Infant Behavioural and Physiological Outcomes, PLoS One, Oct. 2012, at 1, 8. 
 36. Misra, supra note 8, at 291–92. 
 37. Peter D. Gluckman et al., Developmental Origins of Health and Disease: Reducing the Burden 
of Chronic Disease in the Next Generation, Genome Med. (Feb. 24, 2010, 2:14 PM), 
http://www.genomemedicine.com/content/2/2/14. 
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3. Genetic Influences 
Most health and behavioral outcomes are multifactorial in nature, 
which means that across individuals, an outcome of interest (such as 
antisocial behavior) is influenced by many different genes and many 
different environmental factors. This does not, however, preclude the 
possibility that some individuals may have a much simpler etiology (such 
as rare genetic variation). Before describing the role of epigenetic effects 
within DOHaD, it is first necessary to provide a brief overview of how 
genetic variation is associated with health outcomes. 
a. Direct Genetic Effects 
Variation in DNA sequence or chromosomal abnormalities may 
directly influence vulnerability for later health outcomes. For example, 
although environmental factors account for the majority of variability in 
fetal growth,38 genetic effects play a substantial role.39 This example 
highlights the importance of considering the impact of both genetic and 
environmental influences factors on fetal growth (used by many research 
groups as a proxy measure for the quality of the in utero environment) and 
later health outcomes.40 
b. Gene-Environment Correlation 
Although exposure to other risk factors, such as cigarette smoke, are 
categorized as environmental in nature, most environmental risk factors 
are correlated with genetic influences.41 Gene-environment correlation 
takes multiple forms,42 and passive gene-environment correlation may be 
most influential during fetal development. Passive gene-environment 
correlation occurs when the child’s genotype, which is inherited from 
parents, is associated with the environment in which the child is raised.43 
For example, mothers may have a genetic liability to engage in risky 
behavior and pass down this genetic liability to their offspring. However, 
having a genetic liability for risky behavior also makes it more likely that 
the developing fetus is exposed to adverse prenatal exposures that are 
 
 38. Christina M. Hultman et al., Birth Weight and Attention-Deficit/Hyperactivity Symptoms in 
Childhood and Early Adolescence: A Prospective Swedish Twin Study, 46 J. Am. Acad. Child & 
Adolescent Psychiatry 370, 375 (2007). 
 39. Id.; D.O. Mook-Kanamori, Heritability Estimates of Body Size in Fetal Life and Early 
Childhood, PLoS One, July 2013, at 3–7. 
 40. See generally Valerie S. Knopik, Maternal Smoking During Pregnancy and Child Outcomes: 
Real or Spurious Effect?, 34 Developmental Neuropsychology 1 (2009). 
 41. See generally Kenneth S. Kendler & Jessica H. Baker, Genetic Influences on Measures of the 
Environment: A Systematic Review, 37 Psychol. Med. 615 (2007). 
 42. Sara R. Jaffee & Thomas S. Price, The Implications of Genotype–Environment Correlation for 
Establishing Causal Processes in Psychopathology, 24 Dev. & Psychopathology 1253, 1253–54 (2012). 
 43. Id. at 1253. 
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associated with maternal risky behavior, such smoking cigarettes. Thus, it 
is important to disentangle the effects of a genetic liability for risky 
behavior and smoke exposure on later health outcomes by using 
genetically-informed designs. For example, comparing siblings with the 
same mother who were differentially exposed to prenatal smoking parses 
out a genetic liability for risky behavior from maternal smoking during 
pregnancy.44 This genetically informed design would allow for a more 
focused investigation of the effect that maternal smoking during 
pregnancy has on later health outcomes.45 
c. Gene-Environment Interaction  
Gene-environment interaction occurs when the relationship between 
an environmental factor and a later health outcome depends on the 
individual’s or parent’s genotype.46 Great interest in identifying the role of 
gene-environment interactions has been fueled by their potential to 
elucidate processes that underlie health outcomes.47 Gene-environment 
interaction may provide insight into how environmental factors impact 
biological vulnerability for later outcomes, but the exact mechanisms 
underlying these effects are often unknown. Thus, the application of gene-
environment interactions to medical and legal fields48 is frequently limited 
by a lack of understanding of the biological mechanisms underlying these 
effects. Environmentally induced epigenetic modifications may represent 
the most promising biological mechanisms underlying gene-environment 
interactions.49 
II.  Epigenetics of Maternal Smoking During Pregnancy 
A. Epigenetic Mechanisms 
“There are few situations during the life course where . . . gene–
environment interactions[] are more striking than during prenatal 
development.”50 There has been research to better understand the causes 
 
 44. Knopik, supra note 40, at 18. 
 45. Id. 
 46. Terrie E. Moffitt et al., Strategy for Investigating Interactions Between Measured Genes and 
Measured Environments, 62 Archives Gen. Psychiatry 473, 473 (2005). 
 47. Id. 
 48. William Bernet et al., Bad Nature, Bad Nurture, & Testimony Regarding MAOA & SLC6A4 
Genotyping at Murder Trials, 52 J. Forensic Sci. 1362, 1362 (2007). 
 49. See generally R.C. Bagot & M.J. Meaney, Epigenetics & the Biological Basis of Gene × 
Environment Interactions, 49 J. Am. Acad. Child & Adolescent Psychiatry 752 (2010). 
 50. Knopik et al., supra note 24, at 1377; see Matthew A. Maccani & Carmen J. Marsit, Epigenetics in 
the Placenta, 62 Am. J. Reprod. Immunology 78, 78 (2009) (“There are only a few settings where the 
importance of this gene-environment interface is more profound than during intrauterine development, 
where the ‘critical windows’ are narrower and where disruption or modification can influence fetal 
development as well as lead to programming of health throughout the life course.”). 
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and effects of DOHaD, including investigation into the molecular 
mechanisms of fetal programming with a special focus placed on 
epigenetics.51 
Epigenetics is the study of changes in gene expression, or whether a 
gene is turned on or off, that are not caused by changes in the sequence of 
DNA.52 Recent research has suggested that epigenetic mechanisms may be 
the conduit through which environmental factors, like “stress, prenatal 
nutrition, or prenatal drug exposure can lead to changes in gene expression 
from one cell to its daughter cells and, in some cases, from one generation 
to the next.”53 From such analyses, it has been hypothesized that 
epigenetics may be one mechanism through which fetal programming can 
occur.54 Research has discovered four main modes of epigenetic gene 
regulation:55 DNA methylation,56 noncoding RNA-mediated gene 
regulation (especially by microRNA (“miRNA”)),57 imprinting,58 and 
histone modification.59 
 
 51. See Maccani & Marsit, supra note 50, at 78. 
 52. Bird, supra note 3, at 396. 
 53. Knopik, supra note 40, at 1380. See generally Wadhwa, supra note 9, James M. Swanson et al., 
Developmental Origins of Health & Disease: Environmental Exposures, 27 Seminars in Reprod. Med. 391 
(2009). 
 54. See generally Bagot & Meaney, supra note 49. 
 55. For an extensive description of these epigenetic mechanisms, as well the technological 
advances that have made it possible to measure changes to these modes of epigenetic regulation which 
can result in changes to gene expression, see generally Maccani & Marsit, supra note 50. 
 56. DNA methylation is the most widely studied mode of epigenetic gene regulation. In brief, 
DNA methylation involves the attachment of methyl group (an organic compound) to cytosine (one of 
the four main bases of DNA) in cytosine/guanine-rich regions of DNA. A general rule—one that is 
usually, but not always, true—is that when cytosines in the promoter region of a gene are methylated, 
that gene will be effectively silenced by methylation (i.e., the gene would be turned “off”). Conversely, 
when a given stretch of cytosines in the promoter region of a gene are not methylated, that gene will 
not be silenced by methylation (i.e., the gene would remain turned “on”). Research suggests that it is 
not the methylation of DNA itself that contributes most to the shutting off of gene expression but 
rather the altered binding of various proteins to methylated stretches of DNA which leads to 
dysregulation of expression of genes. The removal and resetting of methylation patterns during 
embryonic development make the prenatal period an especially critical window during which the 
environment can have major effects on the offspring. See generally Maccani & Marsit, supra note 50; 
Matthew A. Maccani & Valerie S. Knopik, Cigarette Smoke Exposure-Associated Alterations to Non-
Coding RNA, Frontiers Genetics, Apr. 2012, at 1. 
 57. Ever since early discoveries of RNA as a product of the transcription of DNA, many have 
theorized that RNA may not only act as the intermediate step on the pathway from DNA to protein 
but may also have a degree of regulatory activity itself. Of the types of non coding RNA (“ncRNA”) 
involved in epigenetic gene regulation, the three best-characterized forms are microRNA (“miRNA”), 
Piwi-interacting RNA (“piRNA”), and long non-coding RNA (“long ncRNA”), with miRNA getting 
the most research attention to date. miRNA have been discovered in a variety of species and have 
been shown to be important regulators of a number of biological processes, including development, 
cell cycle regulation, and even cancer progression. miRNA function to regulate gene expression post-
transcriptionally by base pairing to a target mRNA sequence. The specific mechanism of miRNA-
mediated gene regulation appears to be dependent on a number of factors, the most important of 
which appears to be the degree of complementarity between the miRNA sequence and the target 
mRNA sequence. See generally Mariana Lagos-Quintana et al., Identification of Novel Genes Coding 
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for Small Expressed RNAs, 294 Science 853 (2001). As a general rule, perfect complementarity of a 
miRNA to its target mRNA sequence will result in the degradation of the mRNA transcript by a 
mechanism of Argonaute-catalyzed mRNA cleavage. See generally Gyorgy Hutvagner & Phillip D. 
Zamore, A microRNA in a Multiple-Turnover RNAi Enzyme Complex, 297 Science 2056 (2002); Ji-
Joon Song et al., Crystal Structure of Argonaute and Its Implications for RISC Slicer Activity, 
305 Science 1434 (2004); Soraya Yekta et al., MicroRNA-Directed Cleavage of HOXB8 mRNA, 
304 Science 594 (2004). Imperfect sequence complementarity between a miRNA and its target mRNA 
will result in the translational repression of the target mRNA by blocking or altering the function of 
translational machinery through mechanisms, including the inhibition of translation initiation and 
poly(A) shortening. See generally Witold Filipowicz et al., Mechanisms of Post-Transcriptional 
Regulation by microRNAs: Are the Answers in Sight?, 9 Nature Revs. Genetics 102 (2008); Lagos-
Quintana et al., supra note 57. Due to the fact that partial or imperfect complementarity of a miRNA 
to a target mRNA can lead to translational repression which can effectively silence a gene, a single 
miRNA has been observed and speculated to have the capability of regulating a large number of 
genes. See Tingting Du & Phillip D. Zamore, Beginning to Understand microRNA Function, 17 Cell 
Res. 661 (2007). Some research has also pointed to the possibility that miRNA can utilize a 
combination of both translational repression and mRNA degradation as the mechanism for their post-
transcriptional gene regulation, but more work is ongoing to more definitively characterize the 
mechanisms of miRNA-mediated regulation of gene expression. See generally Lee P. Lim et al., 
Microarray Analysis Shows That Some microRNAs Downregulate Large Numbers of Target mRNAs, 
433 Nature 769 (2005); Maccani & Marsit, supra note 50; Matthew A. Maccani & Carmen J. Marsit, 
Exposure and Fetal Growth-Associated miRNA Alterations in the Human Placenta, 2 Clinical 
Epigenetics 401 (2011); Maccani & Knopik, supra note 56. 
 58. Genomic imprinting is the parent-of-origin, allele-specific expression of genes. Imprinted 
genes are theorized to be controlled by both non-coding RNAs and changes in DNA methylation at 
sites in differentially methylated regions (“DMRs”). During imprinting, DNA methylation functions 
to alter the binding of specific transcription factor or enhancer elements (or both) that control the 
allele specific expression of the region. See generally Miguel Constancia et al., Imprinting Mechanisms, 
8 Genome Res. 881 (1998); Maccani & Marsit, supra note 50; Andrew J. Wood & Rebecca J. Oakey, 
Genomic Imprinting in Mammals: Emerging Themes and Established Theories, 2 PLoS Genetics 1677 
(2006). Imprinting has been hypothesized to be one of the mechanisms involved in the “parent 
conflict” theory. The “parent conflict theory” notes that paternally-expressed genes strongly promote 
the utilization of maternal resources to benefit offspring while maternally-expressed genes strongly 
promote the preservation of such maternal resources; thus, these parental influences are in direct 
conflict with one another. Using such logic, one might conclude that paternally-expressed (and 
maternally-imprinted) gene expression attempts to foster the growth of offspring while maternally-
expressed (and paternally-imprinted) gene expression tries to ensure that each offspring has 
approximately the same access to maternal resources as its siblings. See generally C. Badcock & B. 
Crespi, Imbalanced Genomic Imprinting in Brain Development: An Evolutionary Basis for the 
Aetiology of Autism, 19 J. Evolutionary Biology 1007 (2006); Shirley M. Tilghman, The Sins of the 
Fathers and Mothers: Genomic Imprinting in Mammalian Development, 96 Cell 185 (1999). Genes 
regulated by imprinting are involved in a number of processes including embryonic and placental 
development and later-in-life functions such as behaviors and metabolism. Aberrant imprinting 
patterns have been described to lead to well-characterized syndromes (including Praeder-Willi and 
Angelman Syndromes), altered establishment of imprinted genes (particularly at chromosome 11p15), 
and Beckwith-Wiedemann Syndrome, which has also been linked to the use of assisted reproductive 
technologies. See generally Aimee S. Chang et al., Association Between Beckwith-Wiedemann 
Syndrome and Assisted Reproductive Technology: A Case Series of 19 Patients, 83 Fertility & 
Sterility 349 (2005); Michael R. DeBaun et al., Association of In Vitro Fertilization with Beckwith-
Wiedemann Syndrome and Epigenetic Alterations of LIT1 and H19, 72 Am. J. Hum. Genetics 156 
(2003); Anthony R. Isles & Anthony J. Holland, Imprinted Genes and Mother-Offspring Interactions, 
81 Early Hum. Dev. 73 (2005); E.R. Maher et al., Beckwith-Wiedemann Syndrome and Assisted 
Reproduction Technology (ART), 40 J. Med. Genetics 62 (2003); Benjamin Tycko & Ian M. Morison, 
Physiological Functions of Imprinted Genes, 192 J. Cell Physiology 245 (2002). 
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B. Environmental Epigenetics 
Epigenetic mechanisms have been investigated in a variety of settings. 
The subfield of “environmental epigenetics” studies how environmental 
exposures may affect epigenetic mechanisms.60 A special focus of 
“environmental epigenetics” research has been to determine how 
environmental exposures during critical windows and sensitive periods of 
development, such as during pregnancy, might influence epigenetics and 
therefore affect the developing fetus and fetal programming.61 Research in 
both human cohorts and model systems (such as animals) continues to 
characterize the influence of environmental exposures on epigenetics. 
Prenatal exposures may, both directly and indirectly, influence fetal 
programming through epigenetic mechanisms. In addition, these 
epigenetic mechanisms, such as DNA methylation profiles or miRNA 
 
 59. Histone modifications involve the acetylation, methylation, phosphorylation, and 
ubiquitination of histone proteins around which DNA is wrapped, leading to regulation of gene 
expression. See generally Atsushi P. Kimura et al., Epigenetic Modifications at the Human Growth 
Hormone Locus Predict Distinct Roles for Histone Acetylation and Methylation in Placental Gene 
Activation, 18 Molecular Endocrinology 1018 (2004); Bryan M. Turner, Cellular Memory and the 
Histone Code, 111 Cell 285 (2002). Such modifications of the amino-terminal tails of core histones by 
acetylation, phosphorylation, and methylation can determine gene activity by altering the accessibility 
of DNA to factors which can lead to (or repress) gene expression. See Thomas Jenuwein & C.D. Allis, 
Translating the Histone Code, 293 Science 1074 (2001); Brian D. Strahl & C.D. Allis, The Language of 
Covalent Histone Modifications, 403 Nature 41 (2000); Yi Zhang & Danny Reinberg, Transcription 
Regulation by Histone Methylation: Interplay Between Different Covalent Modifications of the Core 
Histone Tails, 15 Genes & Dev. 2343 (2001). Histone methyltransferases—enzymes which aid in the 
transfer of methyl groups to histones—have been identified and characterized, including the H3-K4 
methyltransferase and five H3-K9 methyltransferases. See generally Kenichi Nishioka et al., Set9, 
a Novel Histone H3 Methyltransferase that Facilitates Transcription by Precluding Histone Tail 
Modifications Required for Heterochromatin Formation, 16 Genes & Dev. 479 (2002); Hidesato Ogawa 
et al., A Complex with Chromatin Modifiers that Occupies E2F- and Myc-Responsive Genes in G0 
Cells, 296 Science 1132 (2002); Stephen Rea et al., Regulation of Chromatin Structure by Site-Specific 
Histone H3 Methyltransferases, 406 Nature 593 (2000); David C. Schultz et al., SETDB1: A Novel 
KAP-1-Associated Histone H3, Lysine 9-Specific Methyltransferase that Contributes to HP1-Mediated 
Silencing of Euchromatic Genes by KRAB Zinc-Finger Proteins, 16 Genes & Dev. 919 (2002); Hengbin 
Wang et al., Purification and Functional Characterization of a Histone H3-Lysine 4-Specific 
Methyltransferase, 8 Molecular Cell 1027 (2001); Liu Yang et al., Molecular Cloning of ESET, a 
Novel Histone H3-Specific Methyltransferase that Interacts with ERG Transcription Factor, 
21 Oncogene 148 (2002). Researchers have also described a number of transcription co-activators that 
have characteristic histone acetyltransferase activity and histone deacetylases, which contribute to 
histone modification. See generally En Li, Chromatin Modification and Epigenetic Reprogramming in 
Mammalian Development, 3 Nature Rev. Genetics 662 (2002). As a result, histone modifications can 
turn genes “on” or “off,” depending on which modification has been made. Alterations to patterns of 
histone modification can have a number of consequences, such as developmental dysregulation and 
diseases. Research is continuing to explore how normal and altered histone modifications can control 
gene expression, as well as how such modifications might be involved in regulating additional 
epigenetic processes and disease states. See generally Vincenzo Calvanese et al., Cancer Genes 
Hypermethylated in Human Embryonic Stem Cells, PLoS One, Sept. 2008, at 1. 
 60. Stella M. Reamon-Buettner et al., The Next Innovation Cycle in Toxicogenomics: Environmental 
Epigenetics, 659 Mutation Res. 158, 159 (2008). 
 61. Knopik, supra note 24, at 1377–78. 
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expression, may have utility not only as diagnostic biomarkers capable of 
assessing levels of exposure to prenatal toxicants or predicting increased 
risk for behavioral deficits, diseases, or disease progression, but also as 
potential therapeutic targets. 
C. Harmful Prenatal Exposures: Maternal Smoking During 
Pregnancy and Associated Fetal Outcomes 
During prenatal development, the fetus is especially sensitive to 
harmful effects of a variety of exposures. The placenta, commissioned 
with the role of aiding the fetus during this critical time period, plays a 
crucial role in supporting the normal growth and development of the 
fetus. The placenta provides the fetus with nutrients, assists in waste 
removal, and exhibits a degree of metabolic activity that protects the 
fetus from both maternal immune rejection and from other 
environmental insults.62 As a center for metabolic activity, the placenta 
produces and secretes hormones that support each stage of pregnancy.63 
The placenta is also responsible for the reactions that ultimately protect 
the fetus from exposure to environmental toxicants.64 A number of drugs 
and toxicants—including nicotine,65 alcohol,66 and benzo(a)pyrene67—
have been found to affect placental gene expression, thereby altering the 
ability of the placenta to ensure proper fetal growth and development. 
Maternal cigarette smoking during pregnancy is associated with 
increased risk of a number of pregnancy complications such as 
spontaneous abortion,68 preterm delivery,69 and reduced birth weight.70 
Additional studies have shown that maternal cigarette smoking during 
pregnancy is associated with respiratory disease,71 asthma and allergies,72 
 
 62. Matthew A. Maccani et al., Maternal Cigarette Smoking During Pregnancy Is Associated with 
Downregulation of miR-16, miR-21, and miR-146a in the Placenta, 5 Epigenetics 583, 583 (2010). 
 63. Maccani & Marsit, supra note 50, at 79. 
 64. Id. 
 65. Donna S. Lambers & Kenneth E. Clark, The Maternal and Fetal Physiologic Effects of 
Nicotine, 20 Seminars Perinatology 115, 119–21 (1996). 
 66. See generally John O. Beattie, Transplacental Alcohol Intoxication, 21 Alcohol & Alcoholism 
163 (1986). 
 67. See generally H.J. Guyda et al., Benzo(a)pyrene Inhibits Epidermal Growth Factor Binding and 
Receptor Autophosphorylation in Human Placental Cell Cultures, 37 Molecular Pharmacology 137, (1990). 
 68. Anne Castles et al., Effects of Smoking During Pregnancy: Five Meta-Analyses, 16 Am. J. 
Preventive Med. 208, 211(1999). 
 69. Id. at 212. 
 70. Matthew A. Maccani et al., miR-16 and miR-21 Expression in the Placenta Is Associated with 
Fetal Growth, PLoS One, June 2011, at 1, 5. 
 71. Derek G. Cook & David P. Strachan, Summary of Effects of Parental Smoking on the 
Respiratory Health of Children and Implications for Research, 54 Thorax 357, 357 (1999). 
 72. See Susan L. Prescott & Vicki Clifton, Asthma and Pregnancy: Emerging Evidence of Epigenetic 
Interactions In Utero, 9 Current Opinion in Allergy & Clinincal Immunology 417, 417 (2009). 
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and cancer.73 There are thousands of chemicals in cigarettes, including 
nicotine, benzo(a)pyrene and carbon monoxide; more than forty of these 
chemicals are known carcinogens.74 Previous work has shown that 
nicotine can cross the placenta easily and can cause fetal concentrations 
that are fifteen percent higher than maternal concentrations.75 Taken 
collectively, the vast body of literature describing the harmful effects of 
smoking during pregnancy suggests that maternal smoking remains a 
potentially dangerous common exposure that can have major 
ramifications not only on the normal growth and development of the 
fetus but also on fetal programming.76 
Although several studies have described a decrease in the overall 
prevalence of smoking in women in the past two decades, studies have also 
shown that the prevalence of smoking in young pregnant women under 
twenty years of age has increased to prevalence rates of thirty to forty 
percent.77 Other studies have found that twelve to fifteen percent of all 
women of childbearing age smoke while pregnant.78 In addition to the 
effects of primary smoke exposure (maternal smoking during pregnancy), 
it is necessary to consider the effects of secondhand smoke exposure on 
the developing fetus. Pregnant women and their fetuses may be exposed to 
secondhand smoke in homes, vehicles, the workplace, or public areas. 
Studies suggest that more than 126 million nonsmoking adults are exposed 
to secondhand smoke and that almost sixty percent of children ages three 
to eleven are exposed to secondhand smoke.79 Collectively, cigarette 
smoke remains a common and hazardous exposure, especially at sensitive 
periods of development where exposure can have potentially serious, long-
term effects on health. 
In light of the plethora of scientific data suggesting negative 
consequences associated with smoking during pregnancy, pregnant women 
are cautioned against smoking while pregnant.80 However, despite the 
 
 73. S. P. Doherty et al., Early Life Insult From Cigarette Smoke May Be Predictive of Chronic 
Diseases Later in Life, 14 Biomarkers 97, 99–100 (2009). 
 74. Anja Thielen et al., Tobacco Smoke: Unraveling a Controversial Subject, 60 Experimental & 
Toxicologic Pathology 141, 147 (2008). 
 75. Lambers & Clark, supra note 65, at 116. 
 76. Maccani, supra note 62, at 583. 
 77. Knopik, supra note 24, at 1378. See generally Niina Jaakkola et al., Smoking During 
Pregnancy in Finland: Determinants and Trends, 1987–1997, 91 Am. J. Pub. Health 284 (2001); U.S. 
Dep’t Health & Human Servs., The Health Consequences of Involuntary Exposure to Tobacco 
Smoke: A Report of the Surgeon General (2006). 
 78. Sven Cnattingius, The Epidemiology of Smoking During Pregnancy: Smoking Prevalence, 
Maternal Characteristics, and Pregnancy Outcomes, 6 Nicotine & Tobacco Res. 125, 127 (2004). See 
generally Renee D. Goodwin et al., Mental Disorders and Nicotine Dependence Among Pregnant 
Women in the United States, 109 Obstetrics & Gynecology 875 (2007). 
 79. Knopik, supra note 24, at 1378. See generally U.S. Dep’t Health & Human Servs., supra note 77. 
 80. Knopik, supra note 24, at 1378. See generally Alison K. Shea & Meir Steiner, Cigarette Smoking 
During Pregnancy, 10 Nicotine & Tobacco Res. 267 (2008). See generally Marie D. Cornelius & Nancy L. 
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numerous research articles suggesting undesirable outcomes in children 
exposed to prenatal smoke exposure and warnings encouraging women to 
stop smoking while pregnant, a large percentage of women continue to 
smoke during pregnancy or are exposed to the dangers of secondhand 
smoke during pregnancy. Such figures, as well as the expenditure for 
smoking-associated health problems in mothers, fetuses, and children, 
beg for public health policy initiatives to more effectively communicate 
the potential dangers of smoking during pregnancy, as well as to better 
prevent the potentially harmful exposure to cigarette smoke altogether. 
Considerations for such public health campaigns, such as evidence-based 
policies for reducing maternal and paternal cigarette smoking during 
pregnancy through taxation of cigarettes, increasing public awareness, 
and smoking cessation interventions, are described later in this Article. 
D. Maternal Smoking During Pregnancy: Epigenetics as a 
Potential Link to Future Outcomes? 
A number of studies have investigated links between maternal 
smoking during pregnancy and aberrant epigenetic regulation of gene 
expression, with such dysregulation potentially associated with 
consequences for the fetus throughout the life course. Research by our 
group and others has characterized epigenetic alterations in target tissues 
associated with maternal cigarette smoking during pregnancy. 
1. Maternal Smoking During Pregnancy and DNA Methylation 
Studies of the human placenta have revealed associations between 
maternal cigarette smoking during pregnancy and DNA methylation in a 
gene specific and even global fashion. A group of researchers led by 
Melissa Suter from Baylor College of Medicine observed that maternal 
tobacco use is associated with aberrant placental epigenome-wide DNA 
methylation and gene expression.81 In a separate study, Suter and her 
colleagues described data suggesting that maternal tobacco smoking may 
modify placental cytochrome P450, family 1, subfamily A, polypeptide 1 
(“CYP1A1”) expression by altering methylation at CpG sites proximal 
to the 50-xenobiotic response element transcription factor binding site.82 
CYP1A1 is involved in the metabolism of carcinogenic compounds such 
as polycyclic aromatic hydrocarbons, which are present in cigarette 
smoke. This study found that the placentas of babies born to mothers 
 
Day, Developmental Consequences of Prenatal Tobacco Exposure, 22 Current Opinions in Neurology 
121 (2009). 
 81. See generally Melissa Suter et al., Maternal Tobacco Use Modestly Alters Correlated 
Epigenome-Wide Placental DNA Methylation and Gene Expression, 6 Epigenetics 1284 (2011). 
 82. See generally Melissa Suter et al. In Utero Tobacco Exposure Epigenetically Modifies 
Placental CYP1A1 Expression, 59 Metabolism 1481 (2010). 
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who smoked during pregnancy had significantly lower methylation at 
these sites than babies born to nonsmoking mothers.83 This relative 
decrease in methylation was also significantly correlated with increased 
placental CYP1A1 expression, a finding that may have substantial 
implications for future behavior. 
Charlotte Wilhelm-Benartzi and colleagues showed that differential 
methylation of repetitive elements (stretches of DNA exhibiting a large 
number of repeated bases) in the placenta is associated with birth weight 
percentile and maternal smoking during pregnancy.84 Specifically, they 
found that mean methylation levels of the repetitive element AluYb8 
significantly differed by maternal tobacco use during pregnancy.85 
Overall, these reports suggest that cigarette smoke may elicit some of its 
downstream consequences on placental DNA methylation in both a 
global and site-specific fashion. 
Associations between maternal smoking during pregnancy and 
DNA methylation have also been assessed using blood and specific cell 
types isolated from blood.86 Y. Ba and colleagues used both maternal 
blood and umbilical cord blood to measure specific gene promoter 
methylation in insulin-like growth factor 2 (“IGF2”) , which plays a growth 
factor role in the fetus.87 These results suggested that IGF2 promoter 
methylation in the mother’s blood was associated with secondhand smoke 
exposure, as well as other covariates including vitamin B12 maternal blood 
serum levels and maternal weight gain during pregnancy.88 Mary Beth 
Terry and colleagues investigated leukocyte (white blood cell) DNA 
methylation profiles in a multiethnic birth cohort from New York City.89 
Multivariable models suggested that overall levels of DNA methylation 
were significantly associated with maternal smoking during pregnancy 
and with other covariates.90 Although such studies warrant replication in 
a larger cohort, thereby increasing their applicability and enhancing the 
ability to control for potential confounders, these studies of blood and 
blood-derived cells collectively provide preliminary data important for 
impelling future research into the utilization of DNA methylation 
 
 83. Id. 
 84. See generally Charlotte S. Wilhelm-Benartzi et al., In Utero Exposures, Infant Growth, and 
DNA Methylation of Repetitive Elements and Developmentally Related Genes in Human Placenta, 
120 Envtl. Health Persp. 296 (2012). 
 85. Id. 
 86. See generally Knopik, supra note 24. 
 87. See generally Y. Ba et al., Relationship of Folate, Vitamin B12 and Methylation of Insulin-Like 
Growth Factor-II in Maternal and Cord Blood, 65 Eur. J. Clinical Nutrition 480 (2011). 
 88. Id. 
 89. See generally Mary Beth Terry et al., Genomic DNA Methylation Among Women in a Multiethnic 
New York City Birth Cohort, 17 Cancer Epidemiology, Biomarkers, & Prevention 2306 (2008). 
 90. Id. 
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patterns in cord blood or maternal blood as biomarkers of prenatal 
exposures like smoking. 
Other researchers have also worked to characterize associations 
between maternal smoking during pregnancy and DNA methylation 
profiles linked to brain and neurodevelopmental outcomes. Maria 
Toledo-Rodriguez and colleagues investigated associations of maternal 
cigarette smoking during pregnancy and promoter methylation of brain-
derived neurotrophic factor (“BDNF”) in blood samples from 
adolescents whose mothers had smoked during pregnancy.91 BDNF—
which previous studies have shown is important for long-term memory—
acts on certain neurons of the central nervous system and the peripheral 
nervous system, aids in supporting the survival of existing neurons, and 
encourages the growth and differentiation of new neurons and synapses.92 
Toledo-Rodriguez and colleagues found that exposure to maternal 
cigarette smoking in utero is associated with a greater level of DNA 
methylation in the BDNF exon 6 in adolescents whose mothers smoked 
during pregnancy, suggesting that in utero cigarette smoke exposure may 
have long-term consequences still measurable into adolescence.93 Such 
findings are especially intriguing in light of results suggesting that 
methylation of BDNF may have future utility as a diagnostic blood 
biomarker for depression.94 
Future work will continue to explore DNA methylation as a link 
between maternal cigarette smoking during pregnancy and future health 
outcomes. Such work will be necessary to further understand this link and 
to develop potentially powerful diagnostic biomarkers of both exposure 
and risk for future cigarette smoke exposure-associated disease. 
2. Maternal Smoking During Pregnancy and miRNA 
The body of literature characterizing associations between maternal 
cigarette smoking during pregnancy and miRNA is limited compared to 
the literature exploring associations with DNA methylation. Previous 
work by Maccani and colleagues used a candidate miRNA approach to 
measure changes in four human placental miRNA associated with 
maternal cigarette smoking during pregnancy, finding that maternal 
cigarette smoking during pregnancy was associated with decreased levels 
 
 91. Maria Toledo-Rodriguez et al., Maternal Smoking During Pregnancy Is Associated with 
Epigenetic Modifications of the Brain-Derived Neurotrophic Factor-6 Exon in Adolescent Offspring, 
153B Am. J. Med. Genetics pt. B 1350, 1350–54 (2010). 
 92. See generally Eric J. Huang & Louis F. Reichardt, Neurotrophins: Roles in Neuronal 
Development and Function, 24 Ann. Rev. Neuroscience 677 (2001). 
 93. Toledo-Rodriguez et al., supra note 91, at 1352. 
 94. See generally Manabu Fuchikami et al., DNA Methylation Profiles of the Brain-Derived 
Neurotrophic Factor (BDNF) Gene as a Potent Diagnostic Biomarker in Major Depression, PLoS One, 
Aug. 2011, at 1. 
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of miR-16, miR-21, and miR-146a in the placenta.95 They expanded their 
work to further explore which of the thousands of chemicals in cigarettes 
might be altering miRNA expression in placental cells, finding 
specifically that miR-146a was decreased in placental cells treated with 
nicotine and benzo(a)pyrene—two chemicals previously suggested to 
have negative consequences on the fetus.96 As has been previously 
reviewed,97 these observations were limited by sample size (here, 25), as 
well as lack of extensive data on daily cigarette smoke usage and 
exposure to other environmental toxicants.98 Nonetheless, this analysis 
provides an important first investigation into associations between 
maternal cigarette smoking during pregnancy and altered placental 
miRNA expression. Future work investigating these associations in a 
larger sample set with more extensive exposure information will be key 
to further understand the impact of these associations and the 
consequences for the fetus throughout life. 
3. Maternal Smoking During Pregnancy and Histone Modifications 
Histone modifications have also been investigated for associations 
with maternal smoking during pregnancy. Virender Rehan and 
colleagues injected pregnant rats with nicotine and showed that the pups 
of these nicotine-exposed mothers developed asthma.99 Similarly, when 
these pups were allowed to mature and breed, their resulting pups also 
developed asthma, suggesting that the effects of nicotine exposure may 
be transmitted across several generations even without direct exposure 
of an individual to nicotine.100 The team found that one form of nicotine-
induced acetylation of histone H3 could be blocked by a molecule known 
to protect lungs from asthma, suggesting that nicotine-induced 
acetylation of histone H3 might lead to asthma in both pups directly 
exposed to prenatal nicotine and future generations of pups as a result of 
the prenatal exposure of the pups’ sex cells to nicotine.101 Future 
investigations will be key in order to further elucidate this relationship, 
especially to determine how exposure to cigarette smoke might continue 
to have negative consequences for future generations. 
 
 95. Maccani et al., supra note 62, at 583. 
 96. Id. 
 97. See generally Maccani & Marsit, supra note 57; Maccani & Knopik, supra note 56. 
 98. Maccani et al., supra note 62, at 583. 
 99. See generally Virender K. Rehan et al., Perinatal Nicotine Exposure Induces Asthma in Second 
Generation Offspring, 10 BMC Med. 129 (2012); Grandma’s Curse: Some of the Effects of Smoking 
May Be Passed From Grandmother to Grandchild, The Economist, Nov. 3, 2012, at 82. 
 100. Id. 
 101. Id. 
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E. Expanding Prenatal Cigarette Smoke-Altered Epigenetics to 
Postnatal Outcomes 
As previously noted, researchers have yet to fully explore epigenetic 
mechanisms which may underlie psychological disorders associated with 
maternal cigarette smoking during pregnancy.102 One model that might 
be further tested is that of “behavioral teratogenicity”—namely how fetal 
brain exposure to nicotine and the pathological activation of acetylcholine 
nicotinic receptors during early stages of brain development might lead to 
downstream neurobehavioral consequences.103 Given that there is a high 
degree of comorbidity between nicotine dependence and neuropsychiatric 
conditions,104 researchers have struggled to determine how influential 
exposure to cigarette smoke is on modulating risk for developing 
psychological disorders. Epigenetic mechanisms are one such pathway by 
which cigarette smoke could elicit harmful downstream effects on 
neurobehavior. 
III.  Ethical, Policy, and Legal Considerations 
A. Legal Effects of Prenatal Cigarette Smoke Exposure 
Findings such as how the harmful effects of cigarette smoke 
exposure might be transmitted during prenatal development and across 
generations by epigenetic mechanisms introduce quite a number of 
ethical, policy, and legal questions. Prenatal exposure to cigarette smoke 
and grandmaternal transmission of the harmful effects of cigarette smoke 
(and many other toxicants) may lead to a larger discussion on negligence, 
criminal responsibility, and statutes of limitations. 
To some readers, the notion of being held criminally responsible for 
using substances during pregnancy may seem hypothetical and speculative. 
However, at least thirty-four states’ legal statutes that were originally 
intended to protect children after birth from the dangers associated with 
methamphetamine labs and the trade and use of illicit drugs have been 
extended to protect the health of the fetus and prosecute mothers who use 
substances during pregnancy.105 In a lengthy expose in the New York Times 
entitled “The Criminalization of Bad Mothers,” Ada Calhoun describes 
how states have applied child abuse statutes to effectively punish mothers 
who test positive for methamphetamines and other harmful substances 
 
 102. See generally Knopik, supra note 24. 
 103. See generally Rodrigo Paz et al., Behavioral Teratogenicity Induced by Nonforced Maternal 
Nicotine Consumption, 32 Neuropsychopharmacology 693 (2007). 
 104. See generally Barbara Maughan et al., Prenatal Smoking and Early Childhood Conduct 
Problems: Testing Genetic and Environmental Explanations of the Association, 61 Archives Gen. 
Psychiatry 836 (2004). 
 105. See generally Jean Reith Schroedel et al., Women’s Rights and Fetal Personhood in Criminal 
Law, 7 Duke J. Gender L. & Pol’y 89, 102 (2000). 
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while pregnant or during the delivery of their child.106 Punishments range 
from fines to, in the most egregious cases or in the case of repeated 
offense, imprisonment.107 
Proponents of such practices argue that the punishments act as 
deterrents to such behavior, which has been shown in previous analyses 
to be associated with an increase in a child’s postnatal complications and 
future neurobehavioral issues.108 Supporters of these practices also argue 
that they have enacted such legislation to protect vulnerable members of 
society: children. Opponents of these practices cite studies that report 
that rates of mothers seeking prenatal care in states which have enacted 
such harsh legislation are decreasing.109 Opponents argue that from a 
public health perspective, these findings suggest that such legal practices 
may do more harm than good for children in the long run. Furthermore, 
opponents stress that although substantial scientific evidence exists 
describing associations between prenatal drug exposures and postnatal 
outcomes, the vast majority of these findings are epidemiological in 
nature and such studies were not designed to test the causality of 
whether a drug exposure actually causes a downstream neurobehavioral 
outcome. Regardless of position on the issue, a level of caution, a 
consideration for legal precedent, the intent of the “bad actor,” and a 
considerable knowledge of the body of scientific literature is necessary 
when considering legal practices that effectively criminalize negative 
maternal and paternal behavior during pregnancy. 
Maternal substance use during pregnancy is also often viewed within 
the larger fetal rights debate, which includes the legal definition of 
personhood and laws related to abortion and fetal homicide.110 For 
example, given that a viable fetus is considered a “child” in the state of 
South Carolina, the Supreme Court of South Carolina ruled that 
maternal substance use during pregnancy could be prosecuted as child 
abuse.111 In this domain, the maternal-fetal rights conflict stems from 
interventions aiming to improve fetal health trajectories by altering 
maternal behavior. Although these types of interventions aim to limit 
adverse prenatal environmental exposures (which may improve fetal 
health trajectories), opponents of such interventions argue that they also 
 
 106. Ada Calhoun, The Criminalization of Bad Mothers, N.Y. Times, Apr. 25, 2012, at MM30. 
 107. Id. 
 108. Cynthia Dailard & Elizabeth Nash, State Responses to Substance Abuse Among Pregnant 
Women, Guttmacher Rep. Pub. Pol’y, Dec. 2000, at 1, 5. 
 109. See, e.g., Marilyn L. Poland et al., Punishing Pregnant Drug Users: Enhancing the Flight From 
Care, 31 Drug & Alcohol Dependence 199, 202 (1993); U.S. Gen. Accounting Office, GAO/HRD-
90-198, Drug-Exposed Infants: A Generation at Risk, at 9–10 (1990). 
 110. See generally Schroedel, supra note 105. 
 111. Whitner v. State, 492 S.E.2d 777, 778 (S.C. 1997). 
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have the potential to infringe on women’s autonomy and civil liberties.112 
The maternal-fetal rights conflict is often viewed as a zero sum game, 
meaning that any increase in fetal rights results in a decrease in maternal 
rights, and vice versa. In practice, however, interventions and policies may 
increase both maternal and fetal rights by increasing maternal autonomy 
and fetal health. Therefore, viewing maternal-fetal rights and health as 
complementary, rather than contrary, may allow for interventions and 
policies that are most effective in improving maternal-fetal health.113 
In women, substance abuse disorder onset typically occurs prior to 
conception.114 Women who are substance dependent and become pregnant 
represent important candidates for substance use intervention, education, 
or possibly treatment.115 One’s belief about what causes someone to use 
substances or smoke cigarettes may have an important impact on one’s 
perceptions on the culpability and malleability of maternal smoking during 
pregnancy. Converging lines of evidence demonstrate that smoking 
initiation and nicotine dependence may be the result of both genetic and 
environmental influences;116 however, over one-third of individuals believe 
that genetics do not influence smoking behavior117 and hold overly 
simplified views of how substance abuse develops. Furthermore, other 
types of human behavior and traits are commonly viewed as having either 
genetic or environmental influences,118 a view which contradicts well-
established behavioral genetic findings. 
Oversimplified beliefs that contradict well-established scientific 
findings about what may influence deviant behavior, such as substance 
abuse, may have important legal implications. For example, if an 
individual is led to believe that deviant behavior has predominantly 
genetic origins they will be more likely to believe it is serious,119 
determined, and immutable.120 On the contrary, if deviant behavior is 
believed to result from non-genetic causes, the behavior is seen as more 
 
 112. Deborah Hornstra, A Realistic Approach to Maternal-Fetal Conflict, 28 Hastings Ctr. Rep. 7, 
10 (1998). 
 113. Schroedel, supra note 105, at 117. 
 114. Am. Soc’y Addiction Med., Public Policy Statement on Women, Alcohol and Other Drugs, and 
Pregnancy, 1 (July 11, 2011), http://www.asam.org/docs/publicy-policy-statements/1womenandpregnancy_7-
11.pdf.  
 115. Id. 
 116. See generally Hermine H. Maes et al., A Twin Study of Genetic and Environmental Influences 
on Tobacco Initiation, Regular Tobacco Use and Nicotine Dependence, 34 Psychol. Med. 1251 (2004). 
 117. Alison J. Wright et al., Is Attributing Smoking to Genetic Causes Associated with a Reduced 
Probability of Quit Attempt Success? A Cohort Study, 102 Addiction 1657, 1659 (2007). 
 118. Toby E. Jayaratne et al., The Perennial Debate: Nature, Nurture, or Choice? Black and White 
Americans’ Explanations for Individual Differences, 13 Rev. Gen. Psychol. 24, 27 (2009). 
 119. Jo C. Phelan, Geneticization of Deviant Behavior and Consequences for Stigma: The Case of 
Mental Illness, 46 J. Health & Soc. Behav. 307, 317 (2005). 
 120. Ilan Dar-Nimrod & Steven J. Heine, Genetic Essentialism: On the Deceptive Determinism of 
DNA, 137 Psychol. Bull. 800, 802 (2011). 
Smith_64-HLJ-1619 (Do Not Delete) 9/25/2013 12:24 PM 
August 2013]        MATERNAL SMOKING DURING PREGNANCY  1641 
voluntary, blameworthy, and is elected to receive more severe 
punishments.121 Together, these findings suggest that people’s causal 
attributions of deviant behavior often lack an empirical basis and alter 
beliefs about personal responsibility and appropriate punishment. These 
biases highlight the importance of understanding that the majority of 
health and behavior outcomes are the result of genetic and environmental 
factors, which are both statistically and functionally related. For example, 
genetic factors may predispose individuals to be exposed to particular 
environments122 and environmental exposures influence biological 
vulnerability through a number of mechanisms. 
In moving forward with translating scientific findings into effective 
public health policy, a special focus should be given to prevent harmful 
prenatal exposures, where possible, in the first place, thereby promoting 
fetal health and protecting future children; at the same time, maternal 
and paternal rights need to be acknowledged and protected. 
B. Interventions to Reduce Cigarette Smoke Exposure in Early 
Development 
A variety of interventions are aimed at increasing rates of smoking 
cessation and reducing rates of smoking initiation. The Centers for 
Disease Control and Prevention (“CDC”) recommends a multi-pronged 
approach, including state and community-level interventions, health 
communication, and cessation programs, as well as mechanisms to both 
manage and evaluate such interventions.123 The following discussion is 
not meant to endorse a specific approach to intervention, but rather to 
highlight the relative costs and benefits of approaches that reduce rates 
of smoking in both the general population and in pregnant women. 
1. Legislative Interventions 
Tobacco control spending,124 tobacco counter-marketing, cigarette 
excise taxes, and restricting smoking in public places all represent cost-
effective policies that influence smoke exposure in the population.125 The 
CDC program suggestions126 indicated that higher level and longer 
periods of tobacco control spending were related to a greater reduction 
in smoking prevalence. Every dollar spent on tobacco control spending 
 
 121. Phelan, supra note 119, at 316–17. 
 122. Kendler & Baker, supra note 41, at 620–21. 
 123. Ctrs. for Disease Control & Prevention, Best Practices for Comprehensive Tobacco 
Control Programs 7, 34 (2007). 
 124. Tobacco control spending refers to state and federal money that is used to support efforts to 
prevent or reduce tobacco use. 
 125. Jennifer W. Kahende et al., A Review of Economic Evaluations of Tobacco Control 
Programs, 6 Int’l J. Envtl. Res. & Pub. Health 51, 54–63 (2009). 
 126. Ctrs. for Disease Control & Prevention, supra note 123, at 9. 
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has been estimated to be associated with a health care savings of 
approximately five dollars.127 To the extent that fetal and child exposure to 
smoking puts individuals at risk for later negative health and behavioral 
outcomes, and that risk may be transmitted between generations, current 
cost-effectiveness measures may underestimate the benefits of such 
programs. 
Adams and colleagues found that level of tobacco control spending 
was associated with lower postpartum smoking in older mothers; 
however, there was no relationship between tobacco control spending 
level and reported prenatal smoking.128 One explanation for this is that 
state spending does not reach CDC recommendations,129 while another 
possibility may be that states are failing to most effectively channel funds 
currently designated for tobacco control—for example, by investing in 
programs that consistently underperform or are not effective in 
improving tobacco control. The CDC estimates that states need to spend 
between $9.23 and $18.02 per capita to implement an effective 
comprehensive tobacco control program.130 Currently, the majority of 
states are spending far below such estimates.131 Despite record levels of 
tobacco revenue from taxes and the 1998 Tobacco Master Settlement 
Agreement,132 current tobacco control spending has decreased over the 
past decade. Currently, less than two percent of tobacco related revenue 
is spent on prevention and tobacco cessation programs,133 which is 
associated with state revenues.134 However, in addition to state revenue, 
state tobacco control spending is associated with the level of state 
tobacco production and campaign contributions from tobacco lobbies.135 
These findings suggest that tobacco special interest groups may make it 
more difficult for states to reach spending levels that are needed to 
 
 127. Julia A. Dilley et al., Program, Policy, and Price Interventions for Tobacco Control: Quantifying 
the Return on Investment of a State Tobacco Control Program, 102 Am. J. Pub. Health 22, 24 (2012). 
 128. E. Kathleen Adams et al., Reducing Prenatal Smoking: The Role of State Policies, 43 Am. J. 
Preventive Med. 34, 39 (2012). 
 129. Id. 
 130. Ctrs. for Disease Control & Prevention, supra note 123, at 15. According to the CDC, best 
practices to reduce tobacco use were created from an “evidence-based analyses of scientific literature 
and outcomes of comprehensive state tobacco control programs and interventions.” Id. at 14. For an 
overview on how recommended funding levels for each state were determined, see id. at 111–12. 
 131. Campaign for Tobacco-Free Kids, Broken Promises to Our Children: The 1998 State 
Tobacco Settlement 14 Years Later i (2012). 
 132. See, e.g., Cal. Health & Safety Code §§ 104555–58 (2000) (codifying California’s adoption of 
the Master Settlement Agreement).  
 133. Sabrina Tavernise, States Cut Antismoking Outlays Despite Record Tobacco Revenue, N.Y. 
Times, Dec. 6, 2012, at A.19. 
 134. Adam J. Hoffer & Adam Pellillo, The Political Economy of Tobacco Control Spending, 
19 Applied Econ. Letters 1793, 1795 (2012). 
 135. Id. at 1796. 
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implement the effective tobacco control programs described by the 
CDC.136 
Tobacco counter-marketing and marketing restrictions also aim to 
reduce smoking initiation and increase smoking cessation. In the United 
States, current tobacco health warning labels have remained largely 
unchanged since 1984 and are easily overlooked.137 Four different 
cigarette health warnings in text are currently placed on the side of 
United States cigarette packs. In contrast, more prominent pictorial and 
text cigarette health warnings labels have been utilized in at least forty-
five countries. Investigative analyses suggest that these health warning 
labels effectively increase thoughts about quitting and may decrease 
smoking rates.138 In addition, pictorial cigarette health warnings have been 
shown to increase intentions to quit across a variety of socio-demographic 
and racial or ethnic groups.139 In 2009, The Family Smoking Prevention 
and Tobacco Control Act introduced additional marketing restrictions on 
tobacco products and granted the Food and Drug Administration 
(“FDA”) the authority to regulate tobacco-related marketing.140 As a 
result, the FDA mandated that nine new pictorial and text labels be 
included on cigarette packages beginning September 2012.141 For example, 
one label reads “WARNING: SMOKING DURING PREGNANCY 
CAN HARM YOUR BABY” and is accompanied by a cartoon picture of 
a baby in an incubator.142 The D.C. district court, however, found that the 
FDA mandate violated the tobacco company’s First Amendment 
rights.143 This decision was upheld by a divided court of appeals which 
cited insufficient evidence that pictorial cigarette warning labels reduced 
smoking rates.144 The future use of more graphic tobacco health warnings 
in this country remains unclear and additional research into the influence 
of graphic tobacco health warnings on rates of smoking initiation and 
cessation is needed. 
 
 136. See generally Centers for Disease Control & Prevention, supra note 123. 
 137. Jennifer Cantrell et al., Impact of Tobacco-Related Health Warning Labels Across 
Socioeconomic, Race and Ethnic Groups: Results from a Randomized Web-Based Experiment, PLoS 
One, Jan. 2013, at 1, 1; Thomas N. Robinson & Joel D. Killen, Do Cigarette Warning Labels Reduce 
Smoking? Paradoxical Effects Among Adolescents, 151 Archives Pediatrics & Adolescent Med. 267, 
271–72 (1997). 
 138. David Hammond, Health Warning Messages on Tobacco Products: A Review, 20 Tobacco 
Control 327, 332 (2011); David Hammond et al., Communicating Risk to Smokers: The Impact of 
Health Warnings on Cigarette Packages, 32 Am. J. Preventive Med. 1, 5–6 (2007). 
 139. See generally Cantrell, supra note 137. 
 140. Pub. L. No. 111-31, 123 Stat. 1776, 1777 (2009) (codified as amended at 21 U.S.C. §§ 387–87u 
(2009)). 
 141. Id. § 201(d). 
 142. Cigarette Health Warnings, Food & Drug Admin., http://www.fda.gov/downloads/ 
TobaccoProducts/Labeling/UCM259401.pdf (last visited July 30, 2013).  
 143. R.J. Reynolds Tobacco Co. v. FDA, 845 F. Supp. 2d 266, 277 (D.D.C. 2012). 
 144. R.J. Reynolds Tobacco Co. v. FDA, 696 F.3d 1205, 1222 (D.C. Cir. 2012). 
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Research has shown that increases in cigarette excise taxes may 
reduce the prevalence of smoking in the general population.145 In 
addition, one group of researchers found that amongst pregnant women, 
a one dollar increase in cigarette taxes was associated with a 4.8% 
increase in the probability of smoking cessation by the third trimester, an 
effect that remained largely intact four months after delivery.146 
Furthermore, the relationship between increased cigarette taxes and 
increased smoking cessation did not depend on maternal education, level 
of pre-pregnancy smoking, or parity.147 Parallels have been observed in 
the context of raising minimum prices of alcohol, which could offer hope 
for the potential effectiveness of such increased pricing on reducing 
harms associated with dangerous substances of abuse. In British 
Columbia, a 10% increase in the minimum price for the least expensive 
alcoholic beverages led to a 3.4% decrease in consumption of alcoholic 
beverages148 and a 31.7% decrease in alcohol attributable deaths.149 
Together, these findings suggest that increasing cigarette excise taxes 
may help to reduce smoking rates and smoking-related morbidity and 
mortality. 
Smoking bans in public places (such as restaurants and bars) 
represent another legislative intervention which may impact maternal 
smoking during pregnancy in public places. In addition to the social 
stigma associated with smoking in public during pregnancy,150 this type of 
legislation may be another barrier to smoking in public during 
pregnancy. Evidence suggests that smoking bans in public places are 
generally associated with increased smoking cessation, as well as 
decreased tobacco consumption and secondhand smoke exposure.151 In 
addition, full smoking bans in private workplaces were associated with a 
5% increase in the probability that an expecting mother would quit 
smoking by the third trimester.152 Taken together, smoking bans in public 
places may offer another effective means for reducing fetal exposure to 
 
 145. See generally F.J. Chaloupka et al., Effectiveness of Tax and Price Policies in Tobacco  
Control, 20 Tobacco Control (2011). 
 146. Adams et al., supra note 128, at 37. 
 147. See generally T. Coleman et al., Pharmacological Interventions for Promoting Smoking 
Cessation During Pregnancy, 9 Cochrane Database Systematic Revs. (2012). 
 148. Tim Stockwell et al., Does Minimum Pricing Reduce Alcohol Consumption? The Experience 
of a Canadian Province. 107 Addiction 912, 916 (2012). 
 149. See generally Jinhui Zhao et al., The Relationship Between Minimum Alcohol Prices, Outlet 
Densities and Alcohol Attributable Deaths in British Columbia, 2002–09, 108 Addiction 1059 (2013). 
 150. Leona Bull, et al., Social Attitudes Towards Smoking in Pregnancy in East Surrey: A Qualitative 
Study of Smokers, Former Smokers and Non-Smokers, 13 J. Neonatal Nursing 100, 101 (2007). 
 151. See generally Joanne E. Callinan et al., Legislative Smoking Bans for Reducing Secondhand 
Smoke Exposure, Smoking Prevalence and Tobacco Consumption (Review), Cochrane Database 
Systematic Revs. (2010). 
 152. Adams et al., supra note 127, at 34–35. 
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smoke in utero by reducing maternal rates of smoking and by reducing 
the level of secondhand smoke exposure. 
2. Smoking Cessation Treatment 
Smoking cessation programs have also been shown to increase rates 
of smoking cessation among smokers looking to quit.153 Proactive 
interventions for smokers who are not ready to quit, however, are less 
likely to be effective.154 Smoking cessation programs for pregnant women 
also increase smoking cessation; however, across the most well-
controlled studies (randomized clinical trials and biochemical validation 
of smoking cessation), the mean smoking cessation rate is only four 
percent.155 Although smoking cessation treatments are more effective in 
increasing rates of smoking cessation compared to placebos, there is still 
a need to enhance the effectiveness of such programs. 
Smoking cessation programs may also include pharmacotherapy. 
For example, nicotine replacement therapy (including patches or gum) 
may be effective in increasing smoking cessation in the general 
population, as both a supplement and an independent treatment.156 The 
safety of nicotine replacement therapy in pregnant mothers, however, is 
currently controversial.157 An initial report linked first trimester use of 
nicotine replacement therapy with increased congenital malformations,158 
but a recent meta-analysis found that the relationship between nicotine 
replacement therapy and perinatal outcomes is currently inconclusive.159 
Although other pharmacotherapies for smoking cessation exist (such as 
buproprion and varenicline), the effectiveness and side effects of these 
drugs have not been rigorously examined in pregnant mothers. 
In order to further reduce smoking during pregnancy, it is also 
important to consider that many psychosocial risk factors are associated 
with maternal smoking during pregnancy including160 less education,161 
 
 153. Jerry M. Suls et al., Efficacy of Smoking-Cessation Interventions for Young Adults: A Meta-
Analysis, 42 Am. J. Preventative Med. 655, 660–61(2012). 
 154. Lisa Sanderson Cox et al., Predictors of Early Versus Late Smoking Abstinence Within a 24-
Month Disease Management Program, 13 Nicotine & Tobacco Res. 215, 218 (2011). 
 155. KB Filion et al., The Effect of Smoking Cessation Counselling in Pregnant Women: a Meta-
analysis of Randomised Controlled Trials, 118 BJOG: Int’l J. Obstetrics & Gynaecology 1422, 1424 (2011). 
 156. See generally L.F. Stead & T. Lancaster, Combined Pharmacotherapy and Behavioural 
Interventions for Smoking Cessation, The Cochrane Libr. (2012). 
 157. See generally Coleman et al., supra note 147. 
 158. See generally Maria M. Morales-Suárez-Varela et al., Smoking Habits, Nicotine Use, and 
Congenital Malformations, 107 Obstetrics & Gynecology 51 (2006). 
 159. See generally Coleman et al.. supra note 147. 
 160. Valerie S. Knopik, Commentary: Smoking During Pregnancy—Genes and Environment 
Weigh In, 39 Int’l J. Epidemiology 1203, 1203–04 (2010). 
 161. Brian M. D’Onofrio et al., A Quasi-Experimental Study of Maternal Smoking During 
Pregnancy and Offspring Academic Achievement, 81 Child Dev. 80, 89 tbl.2 (2010). 
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substance dependence and psychiatric comorbidity,162 having a substance 
dependent partner,163 and having a history of criminal conviction.164 This 
suggests that maternal smoking during pregnancy may be maintained, in 
part, by other psychosocial factors and that maternal smoking during 
pregnancy may be a way that mothers cope with such stressors.165 
Mothers who continue to smoke during pregnancy tend to smoke more 
and experience more psychosocial stress than mothers who quit smoking 
during pregnancy.166 Thus, to increase the effectiveness of interventions 
aimed at reducing maternal smoking during pregnancy, it is important to 
also target psychosocial stressors that may contribute to mothers 
maintaining their smoking during pregnancy. 
Conclusion 
The growing application of the DOHaD hypothesis167 and inclusion of 
epigenetic profiling in health and behavioral studies has great potential for 
improving public health. Specifically, the DOHaD paradigm emphasizes 
the importance of early environmental influences, especially prenatal and 
intergenerational environmental effects, in influencing vulnerability for 
later health outcomes. Additionally, epigenetic mechanisms provide 
insight into how the environment may “get under the skin” to influence 
gene expression and vulnerability for later health outcomes. DOHaD and 
epigenetic research findings may have wide-ranging applications in legal 
policy and practice. Such findings may easily be misunderstood or 
misinterpreted, however, due to the complex relationships among 
maternal smoking during pregnancy, epigenetic regulation, and later 
health outcomes. Therefore, any application of these findings to legal 
policy and practice requires great care, as well as a thorough 
understanding of multiple scientific disciplines and legal precedents. 
This Article provides an overview of scientific findings examining 
the interrelationships between maternal smoking during pregnancy, 
epigenetic regulation, and health related outcomes. Maternal smoking 
 
 162. Arpana Agrawal et al., Correlates of Cigarette Smoking During Pregnancy and its Genetic and 
Environmental Overlap with Nicotine Dependence, 10 Nicotine & Tobacco Res. 567, 573–76 (2008). 
 163. Valerie S. Knopik et al., Contributions of Parental Alcoholism, Prenatal Substance Exposure, and 
Genetic Transmission to Child ADHD Risk: A Female Twin Study, 35 Psychol. Med. 625, 630 (2005). 
 164. Brian M. D’Onofrio et al., Familial Confounding of the Association Between Maternal 
Smoking During Pregnancy and Offspring Criminality: A Population-Based Study in Sweden, 
67 Archives Gen. Psychiatry 529, 532–33 (2010). 
 165. William D. Lopez et al., Abuse-Related Post-Traumatic Stress, Coping, and Tobacco Use in 
Pregnancy, 40 J. Obstetric, Gynecologic & Neonatal Nursing 422, 425 (2011). 
 166. See generally Kate E. Pickett et al., The Psychosocial Context of Pregnancy Smoking and 
Quitting in the Millennium Cohort Study, 63 J. Epidemiology & Community Health 474 (2009). 
 167. Peter Gluckman & Mark A. Hanson, Living with the Past: Evolution, Development, and 
Patterns of Disease, 305 Science 1733, 1733 (2004). 
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during pregnancy and other forms of pre- and postnatal smoke exposure 
continue to be associated with negative health consequences.168 
Findings linking maternal smoking during pregnancy with aberrant 
patterns of epigenetic regulation provide insight into how prenatal 
smoke exposure may alter vulnerability for later health outcomes.169 
Furthermore, negative health sequelae associated with cigarette smoke 
exposure may be transmitted from one generation to the next,170 
potentially through intergenerational epigenetic effects.171 These findings 
may provide insight into the nature of the relationship between maternal 
smoking during pregnancy and subsequent offspring health outcomes. 
Due to the study design limitations of several of the human studies 
discussed, it should be noted that these studies were unable to test for a 
causal relationship between maternal smoking during pregnancy and 
later health outcomes; therefore, special care should be taken in 
interpreting the results of such epidemiological studies. Additional 
experimental studies investigating the interrelationships between 
maternal smoking during pregnancy, epigenetic regulation, and offspring 
health outcomes may be needed to test for a causal relationship between 
maternal smoking during pregnancy and later health outcomes. 
Bearing these limitations in mind, findings linking maternal smoking 
during pregnancy to aberrant epigenetic regulation or later offspring 
health outcomes pose important ethical, legal, and policy questions. A 
conflict in maternal-fetal rights may arise when maternal substance use 
leads to a decline in the fetus’s health trajectory or when attempts to 
promote fetal health trajectories infringe on an expecting mother’s 
autonomy.172 To promote fetal health, a variety of states have criminally 
prosecuted mothers who abused substances during pregnancy.173 
However, this practice may have paradoxical effects on fetal health 
because mothers who use substances during pregnancy may be less likely 
to seek prenatal care if they may suffer the consequences of prosecution 
as a result of the criminalization of maternal substance use during 
pregnancy.174 Although maternal and fetal rights are often viewed in 
opposition to one another—as in the case of abortion—this does not 
necessarily hold true for maternal substance use during pregnancy.175 
Viewing maternal-fetal rights and health as complementary may allow 
 
 168. See generally Knopik, supra note 24. 
 169. Id. at 1379–81. 
 170. Misra et al., supra note 8, at 291–92. 
 171. Rehan et al., supra note 99, at 139. 
 172. See generally Hornstra, supra note 112. 
 173. Calhoun, supra note 106. 
 174. Poland et al., supra note 109, at 201–02. 
 175. See generally Schroedel et al., supra note 105. 
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for more effective legal policies and interventions aimed at improving 
fetal health trajectories. 
There are a variety of effective interventions aimed at reducing 
levels of maternal smoking during pregnancy that do not infringe on 
maternal autonomy. The CDC recommends a multi-level approach for 
reducing the public health impact of smoking.176 Tobacco control 
spending, tobacco excise taxes, and smoking bans are all associated with 
decreased smoking in expecting mothers and mothers who recently gave 
birth.177 Specifically, increasing the price of cigarettes by one dollar led to 
a four to five percent increase in smoking cessation among expecting 
mothers.178 These initiatives have been shown to be effective in increasing 
smoking cessation in a small but meaningful percentage of women who 
smoke during pregnancy. Smoking cessation programs targeted 
specifically at women of child bearing age or those who are expecting 
may further reduce rates of prenatal smoke exposures. 
Smoking cessation therapy is effective in the general population of 
smokers who are motivated to quit179 and leads to an approximately 4% 
increase in smoking cessation rates among pregnant women.180 Smoking 
cessation programs targeting smokers who are not ready to quit are less 
likely to be effective.181 Given that maternal substance use during 
pregnancy is associated with a host of additional psychosocial stressors,182 
interventions aimed at reducing smoking during pregnancy may require a 
more comprehensive approach, which addresses factors that serve to 
maintain maternal substance use during pregnancy and beyond. 
In summary, there is a substantial body of evidence linking maternal 
smoking during pregnancy with a variety of negative offspring health 
outcomes. Epigenetic mechanisms may: (1) help to explain how prenatal 
smoke exposure influences biological vulnerability for later health 
outcomes, and (2) be involved in the transmission of the negative effects 
of prenatal smoke exposure from one generation to the next. Legal 
policy and practice will continue to shape the impact that current and 
future epigenetic findings linking prenatal exposures to harmful 
postnatal outcomes will have on both fetal and maternal health. 
Scientifically-informed policy and legal practice will be important as 
policy makers strive to reduce the harms associated with prenatal smoke 
exposure and strike the appropriate balance in the maternal and fetal 
rights debate. 
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